Product Overview
Cinfalair 4mg Chewable Tablets are formulated with Montelukast sodium, a leukotriene receptor antagonist used to manage and prevent asthma symptoms and allergic rhinitis. These tablets are ideal as an add-on therapy for patients whose asthma is not adequately controlled with inhaled corticosteroids. They also help relieve symptoms of seasonal allergies and prevent exercise-induced bronchospasm. The chewable format makes it suitable for pediatric use and convenient for daily administration.
Product Description
Cinfalair 4mg is a well-tolerated oral medication designed for children with mild to moderate persistent asthma or seasonal allergic rhinitis. It offers targeted relief by blocking leukotrienes, which are substances in the body that cause inflammation, swelling, and mucus production. - Type: Chewable tablets - Active Ingredient: Montelukast sodium - Strength: 4mg per tablet - Pack Size: 28 tablets (calendarized blister pack) - Indications: Asthma, seasonal allergic rhinitis, exercise-induced bronchospasm - Formulation: Lactose-free, sucrose-free, gluten-free - Age Group: Pediatric (typically 2–5 years) - Manufacturer: Laboratorios Cinfa S.A. (Spain) - Country of Registration: UAE Features: - Effective control of asthma and allergy symptoms - Convenient chewable format for children - Braille writing on pack for accessibility - Pre-cut, single-dose blister packaging - Free from lactose, sucrose, and gluten Directions of Use - Administer once daily in the evening - Chew thoroughly before swallowing - Follow dosage as prescribed by a healthcare professional - Not intended for relief of acute asthma attacks Age Group - Children (typically 2–5 years)